Caris Life Sciences
IPO on NASDAQ: CAI
Molecular profiling service for personalized cancer diagnosis, treatment selection, and monitoring
Funding
$1.70B
2023
Details
Headquarters
Irving, United States
Website
Milestones
FOUNDING YEAR
2008
IPO
June 2025